Skip to content Skip to footer
Subscribe Now
INSIGHTS+

Know Your Investor: Cormorant Asset Management (September’25 Edition) 

Shots: Welcome to the September edition of Know Your Investor, featuring leading investors fuelling healthcare & life sciences This edition spotlights Cormorant Asset Management, an investment firm focused on biotechnology and healthcare companies In 2024, Cormorant completed 31 investments ~$3.88B, spanning PIPEs, private financings, IPO, and venture rounds. For the full report, contact us at…
September 4, 2025

Read more

INSIGHTS+

Know Your Investor: Venrock Healthcare Capital Partners (August’25 Edition)   

Shots:    Welcome to the August edition of Know Your Investor, featuring leading venture capital firms fuelling innovation in healthcare and life sciences This edition spotlights Venrock Healthcare Capital Partners, a venture capital fund focused on investments in both publicly and privately held healthcare companies In 2024, Venrock Healthcare Capital Partners invested approximately $4.56B across six…
August 7, 2025

Read more

Know Your Investor: Alexandria Venture (May’25 Edition)
INSIGHTS+

Know Your Investor: Alexandria Venture (May’25 Edition)

Shots:    Welcome to the 2025 edition of Know Your Investor, spotlighting leading venture capital firms driving innovation in healthcare. This edition features Alexandria Venture Investments, a firm committed to supporting disruptive life science companies that aim to improve human health. In 2024, the firm invested approximately $2.7B across six public and private funding rounds, adding…
May 15, 2025

Read more

Know Your Investor: Janus Henderson Group Plc (April’25 Edition)
INSIGHTS+

Know Your Investor: Janus Henderson Group Plc (April’25 Edition)

Shots:   Welcome to the 2025 series of Know Your Investor, featuring top venture capital firms focused on healthcare. This edition highlights Janus Henderson Group Plc, a global investment firm managing approximately $378.7B in assets across Equities, Fixed Income, Multi-Asset, and Alternatives. In 2024, the firm invested $5.36B across six funding rounds, adding 39 healthcare and…
April 3, 2025

Read more

Know Your Investor: Orbimed (February’ 25 Edition)
INSIGHTS+

Know Your Investor: Orbimed (February’ 25 Edition)

Shots:   The February edition highlights OrbiMed Advisors, a New York-based investment firm specializing in public and private investments within the healthcare and biotech sectors In 2024, OrbiMed expanded its portfolio by adding 49 companies, investing approximately $6.08B across five funding rounds, including private and debt financing For the complete report, contact us at connect@pharmashots.com OrbiMed primarily…
February 6, 2025

Read more

Know Your Investor RA Capital Management (January’25 Edition)
INSIGHTS+

Know Your Investor: RA Capital Management (January’25 Edition)

Shots:   The January Edition features RA Capital Management, a global multi-stage investment firm dedicated to healthcare and life sciences In 2024, RA Capital added 74 companies to its portfolio, investing approximately $8.5B across seven funding rounds, including private and common funding Welcome to the 2025 series of Know Your Investor, a meticulously crafted report highlighting…
January 16, 2025

Read more

Know Your Investor- Samsara Biocapital (October’24 Edition)
INSIGHTS+

Know Your Investor: Samsara Biocapital (October’24 Edition)

Shots:  A California-based venture capital fund, Samsara Biocapital partners with medical companies and scientists to infuse cutting-edge innovations in medicines  In 2023, Samsara participated in five funding rounds and invested around $2.3B to add 19 companies to its portfolio  For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com …
October 17, 2024

Read more

Know Your Investor: Invus (July’24 Edition)
INSIGHTS+

Know Your Investor: Invus (July’24 Edition)

Shots:   Backed with an evergreen investment strategy, Invus makes investments across several company stages ranging from early growth to turnarounds  In 2023, Invus participated in 6 investment rounds in around 29 companies focusing on biopharma, manufacturing & services, and devices  For a curated report on a specific investor or venture capital, reach out to us…
July 17, 2024

Read more

Load more